![Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection | PNAS Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection | PNAS](https://www.pnas.org/cms/10.1073/pnas.2111600119/asset/8dd7d602-5d2d-46ab-8eb2-cc409048e338/assets/images/large/pnas.2111600119fig01.jpg)
Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection | PNAS
![Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs - ScienceDirect Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S027869152200206X-ga1.jpg)
Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs - ScienceDirect
![Clinical Trial of High-Dose Pegylated-Interferon-Alfa-2b Combined With Phototherapy in Advanced Stage Mycosis Fungoides - JDDonline - Journal of Drugs in Dermatology Clinical Trial of High-Dose Pegylated-Interferon-Alfa-2b Combined With Phototherapy in Advanced Stage Mycosis Fungoides - JDDonline - Journal of Drugs in Dermatology](https://s3.amazonaws.com/dl.jddonline.com/articleimages/20_3_WALKER/Clinical_Trial_of_High_Dose_Pegylated_Interferon_Alfa_2b_Combined_With_Phototherapy_in_Advanced_Stage_Mycosis_Fungoides_Table2.jpg)
Clinical Trial of High-Dose Pegylated-Interferon-Alfa-2b Combined With Phototherapy in Advanced Stage Mycosis Fungoides - JDDonline - Journal of Drugs in Dermatology
![Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis | European Respiratory Society Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis | European Respiratory Society](https://erj.ersjournals.com/content/erj/28/3/496/F1.large.jpg)
Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis | European Respiratory Society
![Type I interferon signaling, regulation and gene stimulation in chronic virus infection - ScienceDirect Type I interferon signaling, regulation and gene stimulation in chronic virus infection - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1044532319300387-gr2.jpg)
Type I interferon signaling, regulation and gene stimulation in chronic virus infection - ScienceDirect
![Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial - The Lancet Neurology Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial - The Lancet Neurology](https://www.thelancet.com/cms/attachment/2000992161/2003663757/gr1.gif)
Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial - The Lancet Neurology
![Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial - The Lancet Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial - The Lancet](https://www.thelancet.com/cms/attachment/2119418385/2093586859/gr1.gif)
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial - The Lancet
![Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C | Nature Reviews Gastroenterology & Hepatology Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnrgastro.2011.21/MediaObjects/41575_2011_Article_BFnrgastro201121_Fig1_HTML.jpg)
Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C | Nature Reviews Gastroenterology & Hepatology
![Frontiers | Type-I Interferon Responses: From Friend to Foe in the Battle against Chronic Viral Infection Frontiers | Type-I Interferon Responses: From Friend to Foe in the Battle against Chronic Viral Infection](https://www.frontiersin.org/files/MyHome%20Article%20Library/233563/233563_Thumb_400.jpg)
Frontiers | Type-I Interferon Responses: From Friend to Foe in the Battle against Chronic Viral Infection
![A Critical Risk Factor for a Major Side Effect of Interferon-Alpha Therapy: Activated Indoleamine 2,3-Dioxygenase 1 is Related to Depressive Symptoms | IntechOpen A Critical Risk Factor for a Major Side Effect of Interferon-Alpha Therapy: Activated Indoleamine 2,3-Dioxygenase 1 is Related to Depressive Symptoms | IntechOpen](https://www.intechopen.com/media/chapter/57164/media/F3.png)